245 related articles for article (PubMed ID: 17011566)
1. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.
Kuller LH; Grandits G; Cohen JD; Neaton JD; Prineas R;
Atherosclerosis; 2007 Nov; 195(1):122-8. PubMed ID: 17011566
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
3. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.
Onat A; Can G; Hergenç G; Uğur M; Yüksel H
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
Rothenbacher D; Brenner H; März W; Koenig W
Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
[TBL] [Abstract][Full Text] [Related]
5. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
[TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
Raichlin ER; McConnell JP; Lerman A; Kremers WK; Edwards BS; Kushwaha SS; Clavell AL; Rodeheffer RJ; Frantz RP
J Heart Lung Transplant; 2007 Aug; 26(8):826-33. PubMed ID: 17692787
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
[TBL] [Abstract][Full Text] [Related]
9. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
Muntner P; Lee F; Astor BC
Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
[TBL] [Abstract][Full Text] [Related]
10. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study.
Kathiresan S; Otvos JD; Sullivan LM; Keyes MJ; Schaefer EJ; Wilson PW; D'Agostino RB; Vasan RS; Robins SJ
Circulation; 2006 Jan; 113(1):20-9. PubMed ID: 16380547
[TBL] [Abstract][Full Text] [Related]
11. Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters.
Wannamethee SG; Tchernova J; Whincup P; Lowe GD; Rumley A; Brown K; Cherry L; Sattar N
Int J Obes (Lond); 2007 Jul; 31(7):1089-98. PubMed ID: 17264850
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.
Vega GL; Barlow CE; Grundy SM; Leonard D; DeFina LF
J Investig Med; 2014 Feb; 62(2):345-9. PubMed ID: 24402298
[TBL] [Abstract][Full Text] [Related]
13. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
Everett BM; Kurth T; Buring JE; Ridker PM
J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
[TBL] [Abstract][Full Text] [Related]
14. [Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly].
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):827-31. PubMed ID: 12895332
[TBL] [Abstract][Full Text] [Related]
15. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Can G
Atherosclerosis; 2007 Mar; 191(1):182-90. PubMed ID: 16678831
[TBL] [Abstract][Full Text] [Related]
16. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
[TBL] [Abstract][Full Text] [Related]
17. The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index.
Coimbra S; Reis F; Nunes S; Viana S; Valente MJ; Rocha S; Catarino C; Rocha-Pereira P; Bronze-da-Rocha E; Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Belo L; Santos-Silva A
Oxid Med Cell Longev; 2019; 2019():3021785. PubMed ID: 30911344
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
[TBL] [Abstract][Full Text] [Related]
19. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
[TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women.
Lawlor DA; Davey Smith G; Ebrahim S; Thompson C; Sattar N
J Clin Endocrinol Metab; 2005 Oct; 90(10):5677-83. PubMed ID: 16076942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
